background image

Paid Clinical Trials Salem

Discover 964 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: 120 recruiting locations
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting
Active & Responsive

Fenofibrate for Prevention of DR Worsening

for
Diabetic Retinopathy
Location: 58 recruiting locations
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18 - 70+

Code: NCT04661358

Phase3, Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: 50 recruiting locations
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
Active & Responsive

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: 76 recruiting locations
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting
Active & Responsive

Can Blood Flow Restriction Therapy Improve Strength and Cross-Sectional Area for Shoulder External Rotators Better Than Exercise Alone?

for
Can Blood Flow Restriction Therapy Augments Strength Gains in the Rotator Cuff,
Location: 1 recruiting location
Sponsor: George Fox University

Sex: All

Age: 18+

Code: NCT04596020

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

BFR Training on a Bike to Augment RC Strength, Leg Strength, and VO2 Peak

for
Can BFR Cycling Augment Strength and VO2peak
Location: 1 recruiting location
Sponsor: George Fox University

Sex: All

Age: 18+

Code: NCT05344391

Recruiting
Active & Responsive

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

for
Recurrent Endometrial Carcinoma,
Location: 219 recruiting locations
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05554328

Phase2, Recruiting
Active & Responsive

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: 194 recruiting locations
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase3, Recruiting
Active & Responsive

Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection

for
Benign Neoplasm
Location: 1 recruiting location
Sponsor: Samaritan Health Services

Sex: All

Age: 18+

Code: NCT05082441

Recruiting
Active & Responsive

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

for
Obesity, Overweight
Location: 29 recruiting locations
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06972459

Phase3, Recruiting